A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

NCT02494999 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

NETWORK

Sponsor class

Conditions

Pneumonia

Interventions

BIOLOGICAL: 13-valent pneumococcal conjugate vaccine
BIOLOGICAL: Prevnar 13

Sponsor

Jiangsu Province Centers for Disease Control and Prevention

Collaborators

[object Object]